News >

Attaining MRD Among Next Steps in the ALL Paradigm

Caroline Seymour
Published: Tuesday, Jun 11, 2019

Nelson Jen An Chao, MD

Nelson Jen An Chao, MD

Therapeutic agents in acute lymphoblastic leukemia (ALL), the most impactful of which may be the CAR T-cell therapies, have shown curative potential as well as underscored the importance of achieving minimal residual disease (MRD) negativity, said Nelson Jen An Chao, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut AllergySep 28, 20191.0
Publication Bottom Border
Border Publication